Stock listing
NASDAQ:MTVA MetaVia Inc. Stock
Home listing (NASDAQ) of MetaVia Inc.
Follow MetaVia Inc. into a list and get an email when it puts out news.
Share price · NASDAQ:MTVA
$1.12 USD -0.07 (-5.9%)
Close on Oct 30, 2026
- Day range
- $1.12 – $1.29 USDOct 30, 2026
- Volume
- 71,172 sharesOct 30, 2026
- Market cap
- $7.38M USDAt the close on Oct 30, 2026 · price × 6.59M shares outstanding
- 52-week range
- $0.966 – $14.85 USDLowest and highest trades, Oct 31, 2025 – Oct 30, 2026
- Traded on an average day
- $118,479 USDMedian day 58,050 shares · last 3 months, Jul 30, 2026 – Oct 30, 2026
Prices by listing
| Listing | Last | Change | Volume | Open | High | Low | Previous close | Price from |
|---|---|---|---|---|---|---|---|---|
| NASDAQ:MTVA · Home | $1.12 USD | -0.07 (-5.9%) | 71,172 | $1.23 | $1.29 | $1.12 | $1.19 | Close on Oct 30, 2026 |
Daily closes
Last 3 months, Jul 30, 2026 – Oct 30, 2026 · NASDAQ:MTVA · USD, adjusted for splits
| Day | Close | Change | % | Open | High | Low | Volume |
|---|---|---|---|---|---|---|---|
| $1.12 | -0.07 | -5.9% | $1.23 | $1.29 | $1.12 | 71,172 | |
| $1.19 | +0.05 | +4.4% | $1.15 | $1.25 | $1.13 | 66,493 | |
| $1.14 | -0.01 | -0.9% | $1.17 | $1.19 | $1.11 | 93,172 | |
| $1.15 | -0.065 | -5.3% | $1.27 | $1.27 | $1.15 | 67,681 | |
| $1.215 | -0.165 | -12.0% | $1.41 | $1.41 | $1.215 | 135,384 | |
| $1.38 | -0.01 | -0.7% | $1.39 | $1.50 | $1.36 | 99,600 | |
| $1.39 | +0.05 | +3.7% | $1.35 | $1.395 | $1.35 | 33,100 | |
| $1.34 | +0.05 | +3.9% | $1.29 | $1.37 | $1.29 | 42,200 | |
| $1.29 | +0.06 | +4.9% | $1.26 | $1.32 | $1.20 | 21,000 | |
| $1.23 | -0.03 | -2.4% | $1.29 | $1.32 | $1.225 | 54,300 | |
| $1.26 | -0.11 | -8.0% | $1.38 | $1.43 | $1.26 | 75,700 | |
| $1.37 | +0.01 | +0.7% | $1.35 | $1.44 | $1.325 | 50,100 | |
| $1.36 | -0.07 | -4.9% | $1.40 | $1.435 | $1.35 | 40,500 | |
| $1.43 | -0.02 | -1.4% | $1.52 | $1.52 | $1.415 | 65,400 | |
| $1.45 | +0.04 | +2.8% | $1.43 | $1.589 | $1.41 | 137,000 | |
| $1.41 | +0.07 | +5.2% | $1.35 | $1.44 | $1.35 | 49,600 | |
| $1.34 | -0.12 | -8.2% | $1.47 | $1.48 | $1.33 | 112,000 | |
| $1.46 | -0.02 | -1.4% | $1.47 | $1.52 | $1.46 | 30,800 | |
| $1.48 | -0.06 | -3.9% | $1.52 | $1.54 | $1.45 | 86,100 | |
| $1.54 | 0.00 | 0.0% | $1.55 | $1.587 | $1.54 | 53,100 | |
| $1.54 | 0.00 | 0.0% | $1.56 | $1.65 | $1.51 | 61,400 | |
| $1.54 | -0.03 | -1.9% | $1.59 | $1.605 | $1.52 | 46,600 | |
| $1.57 | -0.09 | -5.4% | $1.64 | $1.66 | $1.55 | 65,100 | |
| $1.66 | -0.01 | -0.6% | $1.64 | $1.67 | $1.61 | 26,100 | |
| $1.67 | +0.01 | +0.6% | $1.65 | $1.70 | $1.62 | 135,000 | |
| $1.66 | +0.03 | +1.8% | $1.68 | $1.68 | $1.61 | 28,700 | |
| $1.63 | 0.00 | 0.0% | $1.662 | $1.662 | $1.61 | 63,600 | |
| $1.63 | -0.05 | -3.0% | $1.65 | $1.665 | $1.61 | 37,600 | |
| $1.68 | +0.01 | +0.6% | $1.69 | $1.69 | $1.64 | 31,300 | |
| $1.67 | -0.06 | -3.5% | $1.65 | $1.701 | $1.64 | 45,300 | |
| $1.73 | +0.14 | +8.8% | $1.55 | $1.73 | $1.55 | 103,800 | |
| $1.59 | +0.05 | +3.2% | $1.551 | $1.59 | $1.52 | 38,900 | |
| $1.54 | -0.04 | -2.5% | $1.57 | $1.59 | $1.52 | 45,700 | |
| $1.58 | -0.04 | -2.5% | $1.67 | $1.67 | $1.56 | 52,600 | |
| $1.62 | -0.04 | -2.4% | $1.64 | $1.87 | $1.60 | 76,600 | |
| $1.66 | -0.09 | -5.1% | $1.75 | $1.795 | $1.65 | 57,000 | |
| $1.75 | +0.01 | +0.6% | $1.75 | $1.83 | $1.74 | 104,900 | |
| $1.74 | +0.04 | +2.4% | $1.70 | $1.85 | $1.52 | 609,300 | |
| $1.70 | -0.05 | -2.9% | $1.76 | $1.81 | $1.70 | 42,800 | |
| $1.75 | -0.09 | -4.9% | $1.82 | $1.85 | $1.70 | 81,100 | |
| $1.84 | +0.02 | +1.1% | $1.803 | $1.93 | $1.78 | 82,900 | |
| $1.82 | +0.10 | +5.8% | $1.70 | $1.84 | $1.699 | 79,600 | |
| $1.72 | 0.00 | 0.0% | $1.69 | $1.73 | $1.65 | 51,400 | |
| $1.72 | +0.02 | +1.2% | $1.70 | $1.74 | $1.68 | 23,300 | |
| $1.70 | +0.04 | +2.4% | $1.69 | $1.732 | $1.67 | 37,700 | |
| $1.66 | -0.02 | -1.2% | $1.69 | $1.73 | $1.65 | 39,700 | |
| $1.68 | +0.04 | +2.4% | $1.56 | $1.69 | $1.56 | 48,600 | |
| $1.64 | +0.11 | +7.2% | $1.53 | $1.80 | $1.53 | 246,600 | |
| $1.53 | +0.07 | +4.8% | $1.44 | $1.53 | $1.44 | 37,900 | |
| $1.46 | +0.02 | +1.4% | $1.45 | $1.495 | $1.45 | 42,100 | |
| $1.44 | -0.03 | -2.0% | $1.47 | $1.47 | $1.43 | 42,200 | |
| $1.47 | -0.02 | -1.3% | $1.46 | $1.50 | $1.442 | 86,300 | |
| $1.49 | +0.01 | +0.7% | $1.48 | $1.53 | $1.435 | 74,900 | |
| $1.48 | -0.01 | -0.7% | $1.50 | $1.535 | $1.46 | 59,100 | |
| $1.49 | +0.03 | +2.1% | $1.47 | $1.52 | $1.464 | 69,200 | |
| $1.46 | -0.01 | -0.7% | $1.47 | $1.481 | $1.43 | 141,700 | |
| $1.47 | +0.05 | +3.5% | $1.45 | $1.52 | $1.42 | 211,800 | |
| $1.42 | -0.01 | -0.7% | $1.45 | $1.47 | $1.42 | 51,600 | |
| $1.43 | -0.06 | -4.0% | $1.44 | $1.50 | $1.43 | 76,800 | |
| $1.49 | +0.04 | +2.8% | $1.43 | $1.54 | $1.43 | 108,100 | |
| $1.45 | -0.04 | -2.7% | $1.489 | $1.505 | $1.45 | 37,200 | |
| $1.49 | +0.03 | +2.1% | $1.48 | $1.51 | $1.44 | 46,600 | |
| $1.46 | -0.02 | -1.4% | $1.48 | $1.53 | $1.46 | 64,000 | |
| $1.48 | +0.06 | +4.2% | $1.48 | $1.56 | $1.451 | 35,400 | |
| $1.42 | -0.02 | -1.4% | $1.41 | $1.46 | $1.38 | 133,200 | |
| $1.44 | 0.00 | 0.0% | $1.47 | $1.47 | $1.41 | 49,100 |
- Ticker
- NASDAQ:MTVA
- Asset type
- Stock
- Sector
- Health care
- Industry
- Biotechnology
- Exchange
- NASDAQ
- Currency
- USD
What changed lately
Latest news release · Oct 28, 2026
MetaVia to Present Phase 1 Clinical Trial Data for DA-1726 in Oral Presentation at the Precision Liver Symposium 2026
Latest deck · August 2026
Investor Presentation (August 2026)
Investor deck · 37 slides
Latest news
MetaVia to Present Phase 1 Clinical Trial Data for DA-1726 in Oral Presentation at the Precision Liver Symposium 2026
Oct 28, 2026
Closed $1.14 (-0.9%) on Oct 28, 2026
MetaVia Appoints Seasoned Clinical Development Executive Sarah Browne, M.D., as Chief Medical Officer
Oct 13, 2026
Closed $1.43 (-1.4%) on Oct 13, 2026
MetaVia Announces Preclinical Findings Supporting Biological Rationale for DA-1726's Waist Circumference Reduction
Sep 9, 2026
Closed $1.74 (+2.4%) on Sep 9, 2026
MetaVia Reports Second Quarter 2026 Financial Results and Provides Corporate Update
Aug 6, 2026
Closed $1.49 (+2.8%) on Aug 7, 2026
MetaVia Announces Completion of Dose Titration in Phase 1 Part 3 Study of DA-1726 for the Treatment of Obesity
Jul 9, 2026
Closed $1.73 (+10.9%) on Jul 9, 2026
MetaVia Presents New Late-Breaking Obesity and Metabolic Data at the ADA 2026 Scientific Sessions Supporting DA-1726 Differentiation and Vanoglipel Combination Potential
Jun 8, 2026
Closed $2.22 (-13.6%) on Jun 8, 2026
MetaVia Presents Higher-Dose Phase 1 Results for DA-1726 at EASL Congress 2026, Supporting Potential in Obesity and MASH
May 27, 2026
Closed $3.34 (+12.5%) on May 27, 2026
MetaVia Highlights Peer-Reviewed Publication Supporting the Anti-Fibrotic Potential of Vanoglipel in MASH
May 20, 2026
Closed $2.89 (+53.7%) on May 20, 2026
MetaVia to Present Obesity Data at the American Diabetes Association's (ADA) 2026 Scientific Sessions
May 18, 2026
Closed $1.11 (0.0%) on May 18, 2026
MetaVia Reports First Quarter 2026 Financial Results and Provides Corporate Update
May 14, 2026
Closed $1.11 (-6.7%) on May 15, 2026
Decks
Investor Presentation (August 2026)
Investor deck · 37 slides · August 2026
Investor Presentation (May 2026)
Investor deck · 37 slides · May 14, 2026
Investor Presentation (March 2026)
Investor deck · 37 slides · Mar 26, 2026
IPO Roadshow (January 2026)
IPO roadshow · 52 slides · Jan 6, 2026
MetaVia Inc. on 6ix
- Sector
- Health care
- Industry
- Biotechnology
- News releases
- 30 in the last 12 months · 109 in all · newest Oct 28, 2026 · oldest 2021
- Decks
- 24 decks · latest August 2026
Where MetaVia Inc. is listed
| Listing | Exchange | Country | Currency |
|---|---|---|---|
| NASDAQ:MTVA · Home listing · This page | NASDAQ | United States | USD |
| BOATS:MTVA | BOATS | United States | USD |
Log in to ask 6ix AI your own questions about MetaVia Inc.